top of page

RINVOQ EXTENDED-RELEASE TABLET 15MG

Product details

Registration number: SIN15959P

Classification: Prescription Only

Active ingredients: Upadacitinib Hemihydrate eqv Upadacitinib

Strength: 15mg

Dosage form: TABLET, FILM COATED, EXTENDED RELEASE

Route: ORAL

Registrant: ABBVIE PTE. LTD.

ATC code: L04AA44

HSA approval date: 16 June 2020

Manufacturer(s):

  • AbbVie Ireland NL B.V.
  • AbbVie S.r.l. (Primary and Secondary Packager)

Manufacturing country/countries: ITALY; IRELAND

What are the HSA registration number and classification for RINVOQ EXTENDED-RELEASE TABLET 15MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15959P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for RINVOQ EXTENDED-RELEASE TABLET 15MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Upadacitinib Hemihydrate eqv Upadacitinib

Strength: 15mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for RINVOQ EXTENDED-RELEASE TABLET 15MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, FILM COATED, EXTENDED RELEASE

Route: ORAL

Source for this answer

Who is the recorded registrant for RINVOQ EXTENDED-RELEASE TABLET 15MG?

According to the HSA dataset updated 7 August 2026:

Registrant: ABBVIE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for RINVOQ EXTENDED-RELEASE TABLET 15MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • AbbVie Ireland NL B.V.
  • AbbVie S.r.l. (Primary and Secondary Packager)

Manufacturing country/countries: ITALY; IRELAND

Source for this answer

Where can I look up RINVOQ EXTENDED-RELEASE TABLET 15MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15959P or the exact product name RINVOQ EXTENDED-RELEASE TABLET 15MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this RINVOQ EXTENDED-RELEASE TABLET 15MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this RINVOQ EXTENDED-RELEASE TABLET 15MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15959P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page